Le Lézard
Classified in: Health, Science and technology
Subjects: Trade Show, Webcast

Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference


Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the "Company") today announced that the company will deliver a corporate presentation during the 2021 Jefferies London Healthcare Conference -- November 16-19, 2021. The presentation will be available to all conference attendees on demand (link here) beginning on Thursday, November 18 at 8 am GMT/3 am EST through Friday, November 19 at 5 pm GMT/12 pm EST.

Interested parties can also register and access the on-demand webcast through the Investor section of the Aurinia corporate website - www.auriniapharma.com, under "News/Events."

ABOUT AURINIA

Aurinia is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company recently introduced the first FDA-approved oral therapy indicated for the treatment of adult patients with active lupus nephritis (LN). Aurinia's head office is in Victoria, British Columbia; its U.S. commercial hub is in Rockville, Maryland; and the Company focuses development efforts globally.


These press releases may also interest you

at 15:00
Parenteral Drug Association, Inc. (PDA) and UK-based Euromed Communications today announced the publication of Industrial Pharmaceutical Microbiology: Quality Control. This 500-page book includes 20 chapters from 19 industry leaders in pharmaceutical...

at 15:00
Children of America® (COA), held a red-carpet Awards Gala at the 2024 Leadership Summit April 6th in New Jersey. The transformative event gathered company leaders to honor one of their own heroic teachers and recognize the exceptional individuals...

at 14:24
Evermore Cannabis Company, a leader in innovative cannabis cultivation and product development, is thrilled to announce its remarkable success at the first-ever Maryland Leaf Bowl, held on April 13th. Demonstrating excellence across multiple...

at 14:23
Autolomous, the market-leading developer of critical manufacturing management systems for cell and gene therapies, and BioCentriq, industry-leading clinical-phase Cell Therapy CDMO (contract development and manufacturing organization), announce a...

at 14:15
As patients with congenital heart diseases live longer, researchers are attempting to understand some of the other complications they may face as they age. In a new study, a team from Children's Hospital of Philadelphia (CHOP) used state-of-the-art...

at 14:08
Seacoast Laboratory Data Systems, a nationwide leader in providing customizable LIS and AR software solutions for commercial and...



News published on and distributed by: